GO2 Foundation for Lung Cancer (GO2 Foundation) presented Heather Wakelee, MD, FASCO, with the 2021 Bonnie J. Addario Lectureship Award at the Physicians’ Education Resource 22nd Annual International Lung Cancer Congress on July 30 in Huntington Beach, California. Dr. Wakelee is Professor of Medicine and Chief of the Division of Oncology at Stanford University and Deputy Director of the Stanford Cancer Institute.
Heather Wakelee, MD, FASCO
GO2 Foundation recognized Dr. Wakelee for her decades of dedication to lung cancer research, covering multiple facets of the disease. Dr. Wakelee’s research has focused on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF, and others. She has led numerous clinical trials focused on lung cancer therapy, most notably involving treatments to improve cures for patients with the disease who have undergone surgery. Dr. Wakelee has also collaborated with colleagues on work geared toward better understanding of why lung cancer develops and identifying enhanced methods for detection.
An Active Investigator
A graduate of Princeton University and Johns Hopkins University School of Medicine, Dr. Wakelee completed her postgraduate training at Stanford University. She serves as Stanford’s principal investigator and on the Executive Committee for the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN), and she is a Fellow of ASCO (FASCO).
Dr. Wakelee’s work in immunotherapy of thoracic malignancies includes participation in multiple phase III trials of PD-L1 checkpoint inhibitors in advanced-stage non–small cell lung cancer. Most recently, she has been involved in steering committees for two phase III international trials exploring immune checkpoint inhibitors during the perioperative period. Dr. Wakelee actively collaborates with many basic scientists at Stanford University seeking to better understand molecular and other biomarkers of immune response.
